337 related articles for article (PubMed ID: 17973185)
21. alpha 2,3-Sialylation of terminal GalNAc beta 1-3Gal determinants by ST3Gal II reveals the multifunctionality of the enzyme. The resulting Neu5Ac alpha 2-3GalNAc linkage is resistant to sialidases from Newcastle disease virus and Streptococcus pneumoniae.
Toivonen S; Aitio O; Renkonen O
J Biol Chem; 2001 Oct; 276(40):37141-8. PubMed ID: 11479313
[TBL] [Abstract][Full Text] [Related]
22. Purification and enzymatic characterization of CMP-sialic acid: beta-galactosyl1----3-N-acetylgalactosaminide alpha 2----3-sialyltransferase from human placenta.
Joziasse DH; Bergh ML; ter Hart HG; Koppen PL; Hooghwinkel GJ; Van den Eijnden DH
J Biol Chem; 1985 Apr; 260(8):4941-51. PubMed ID: 3988739
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the second type of human beta-galactoside alpha 2,6-sialyltransferase (ST6Gal II), which sialylates Galbeta 1,4GlcNAc structures on oligosaccharides preferentially. Genomic analysis of human sialyltransferase genes.
Takashima S; Tsuji S; Tsujimoto M
J Biol Chem; 2002 Nov; 277(48):45719-28. PubMed ID: 12235148
[TBL] [Abstract][Full Text] [Related]
24. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
25. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
26. Genetically altered mice with different sialyltransferase deficiencies show tissue-specific alterations in sialylation and sialic acid 9-O-acetylation.
Martin LT; Marth JD; Varki A; Varki NM
J Biol Chem; 2002 Sep; 277(36):32930-8. PubMed ID: 12068010
[TBL] [Abstract][Full Text] [Related]
27. Evolutionary history of the alpha2,8-sialyltransferase (ST8Sia) gene family: tandem duplications in early deuterostomes explain most of the diversity found in the vertebrate ST8Sia genes.
Harduin-Lepers A; Petit D; Mollicone R; Delannoy P; Petit JM; Oriol R
BMC Evol Biol; 2008 Sep; 8():258. PubMed ID: 18811928
[TBL] [Abstract][Full Text] [Related]
28. Delineation of the minimal catalytic domain of human Galbeta1-3GalNAc alpha2,3-sialyltransferase (hST3Gal I).
Vallejo-Ruiz V; Haque R; Mir AM; Schwientek T; Mandel U; Cacan R; Delannoy P; Harduin-Lepers A
Biochim Biophys Acta; 2001 Oct; 1549(2):161-73. PubMed ID: 11690653
[TBL] [Abstract][Full Text] [Related]
29. Computational analysis of the structure, glycosylation and CMP binding of human ST3GAL sialyltransferases.
Uslupehlivan M; Şener E; İzzetoğlu S
Carbohydr Res; 2019 Dec; 486():107823. PubMed ID: 31557542
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
31. An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas.
Burchell J; Poulsom R; Hanby A; Whitehouse C; Cooper L; Clausen H; Miles D; Taylor-Papadimitriou J
Glycobiology; 1999 Dec; 9(12):1307-11. PubMed ID: 10561455
[TBL] [Abstract][Full Text] [Related]
32. Adult onset cardiac dilatation in a transgenic mouse line with Galβ1,3GalNAc α2,3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy.
Suzuki O; Kanai T; Nishikawa T; Yamamoto Y; Noguchi A; Takimoto K; Koura M; Noguchi Y; Uchio-Yamada K; Tsuji S; Matsuda J
Proc Jpn Acad Ser B Phys Biol Sci; 2011; 87(8):550-62. PubMed ID: 21986317
[TBL] [Abstract][Full Text] [Related]
33. Comparison of genomic structures of four members of beta-galactoside alpha2,3-sialyltransferase genes in the mouse.
Takashima S; Tsuji S
Cytogenet Cell Genet; 2000; 89(1-2):101-6. PubMed ID: 10894948
[TBL] [Abstract][Full Text] [Related]
34. Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.
Cheng J; Yu H; Lau K; Huang S; Chokhawala HA; Li Y; Tiwari VK; Chen X
Glycobiology; 2008 Sep; 18(9):686-97. PubMed ID: 18509108
[TBL] [Abstract][Full Text] [Related]
35. Over-expression of ST3Gal-I promotes mammary tumorigenesis.
Picco G; Julien S; Brockhausen I; Beatson R; Antonopoulos A; Haslam S; Mandel U; Dell A; Pinder S; Taylor-Papadimitriou J; Burchell J
Glycobiology; 2010 Oct; 20(10):1241-50. PubMed ID: 20534593
[TBL] [Abstract][Full Text] [Related]
36. Developmental patterns of GalBeta1,3(4)GlcNAc alpha2,3-sialyltransferase (ST3Gal III) expression in the mouse: in situ hybridization using DIG-labeled RNA probes.
Ji MY; Lee YC; Kim KS; Cho JW; Jung KY; Kim CH; Choo YK
Arch Pharm Res; 1999 Jun; 22(3):243-8. PubMed ID: 10403125
[TBL] [Abstract][Full Text] [Related]
37. Marine invertebrate sialyltransferase of the sea squirt Ciona savignyi sialylated core 1 O-linked glycans.
Kim S; Lee J; Oh DB; Kwon O
Int J Biol Macromol; 2022 Jan; 194():366-376. PubMed ID: 34813786
[TBL] [Abstract][Full Text] [Related]
38. Identification and Biochemical Characterization of the Novel α2,3-Sialyltransferase WbwA from Pathogenic Escherichia coli Serotype O104.
Czuchry D; Desormeaux P; Stuart M; Jarvis DL; Matta KL; Szarek WA; Brockhausen I
J Bacteriol; 2015 Dec; 197(24):3760-8. PubMed ID: 26391208
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.
Sproviero D; Julien S; Burford B; Taylor-Papadimitriou J; Burchell JM
J Biol Chem; 2012 Dec; 287(53):44490-7. PubMed ID: 23275522
[TBL] [Abstract][Full Text] [Related]
40. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
